Flumazenil

Overview

Mechanism of Action

• Competitively binds the benzodiazepine site on the GABA-A receptor (between the α and γ subunits) without intrinsic agonist activity at standard doses.
• Displaces bound benzodiazepines, rapidly reversing sedation, anxiolysis, amnesia, and respiratory depression.
• It does NOT reverse barbiturates, opioids, ethanol, or other non-benzodiazepine GABA-A modulators — though as Harrison's (p. 13018) notes, resolution of altered mental status after IV flumazenil is "virtually diagnostic of benzodiazepine intoxication."

Pharmacokinetics

Critical point: Because flumazenil's half-life is far shorter than most benzodiazepines (e.g., diazepam t½ ~20–100 hours), re-sedation is expected. Repeated dosing or infusion is often needed.

Dosing

Benzodiazepine Overdose / Reversal

• Initial dose: 0.2 mg IV over 15 seconds
• Repeat: 0.2 mg every 1–2 minutes as needed
• Maximum cumulative dose: 1–3 mg (up to 5 mg in some protocols)
• As noted in Best Practices in the Cardiac Catheterization Laboratory (p. 7): 0.2 mg IV every 2–5 minutes, max 1 mg in procedural sedation contexts.

Procedural Sedation Reversal

• Same titration as above; typically 0.2–0.5 mg total is sufficient.

Clinical Uses

1. Reversal of iatrogenic benzodiazepine sedation (e.g., procedural/endoscopic sedation)
2. Benzodiazepine overdose — both for treatment and diagnosis
3. Hepatic encephalopathy (experimental; some evidence benzodiazepine-like ligands accumulate)
4. Diagnostic tool — a dramatic response confirms benzodiazepine etiology (Harrison's, p. 13018)

Contraindications & Cautions

Absolute / High-Risk Contraindications

Relative Cautions

• Mixed overdose (unknown ingestion) — use with caution
• Chronic benzodiazepine use — even therapeutic doses create dependency
• Hepatic impairment — metabolism slowed, may prolong or intensify effect

Adverse Effects

• Seizures (most dangerous — especially in BZD-dependent patients)
• Nausea/vomiting
• Anxiety, agitation, tremor
• Re-sedation (once flumazenil wears off)
• Rarely: arrhythmias, flushing

Key Clinical Pearls

1. Do not use as a routine "coma cocktail" — its use in undifferentiated overdose is controversial and potentially harmful.
2. Re-sedation monitoring is mandatory for at least 1–2 hours (or longer depending on BZD ingested).
3. Flumazenil does NOT reverse respiratory depression from opioids — use naloxone for that.
4. In mixed BZD + opioid overdose, address the opioid component with naloxone first; flumazenil is adjunctive.
5. Not dialyzable in a clinically meaningful way due to high protein binding and hepatic clearance.

Summary Table